The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi最新文献

{"title":"Stool DNA-based SDC2 Methylation Test for the Screening of Colorectal Neoplasia in an Asymptomatic, Average-Risk Population.","authors":"Hyoung Il Choi, Jae Myung Cha, Young Sang Kim, Dae Hyeon Cho, Han Ju Pack, Soo-Young Na, Ji Hye Kim, Hyun Gun Kim, Young-Jin Park, Hye Jung Kwon, Kyeong Ok Kim, Geon Ho Lee, Yoo Jin Lee","doi":"10.4166/kjg.2025.129","DOIUrl":"10.4166/kjg.2025.129","url":null,"abstract":"<p><strong>Background/aims: </strong>Programmatic screening for colorectal cancer (CRC) could maximize the impact of screening in the average-risk population, but the diagnostic performance of a stool DNA-based <i>Syndecan-2</i> methylation (<i>meSDC2</i>) test has only been reported in case-control studies or high-risk populations. This study examined the performance of a stool DNA-based <i>meSDC2</i> test for CRC in an average-risk population from a real-world setting.</p><p><strong>Methods: </strong>This retrospective, multicenter study included consecutive asymptomatic, average-risk individuals for CRC who completed a <i>meSDC2</i> stool test at 18 hospitals. The clinical performance of the <i>meSDC2</i> stool test, including the positive rate, adherence to confirmatory colonoscopy, and the positive predictive value (PPV) for colorectal neoplasia (CRN), was assessed.</p><p><strong>Results: </strong>Over 54 months, 4,910 individuals completed the <i>meSDC2</i> stool test, with 249 (5.1%) testing positive. The colonoscopy compliance rate after a positive test was 61.0% (n=152). Among 121 individuals with available colonoscopy data, the PPV for any CRN, advanced neoplasia, and CRC were 39.7%, 12.4%, and 2.5%, respectively. Colonoscopy after a positive <i>meSDC2</i> test ensured a high-quality examination, as reflected by the 100% cecal intubation rate, 97.5% adequate preparation quality, and an average withdrawal time of 11.2 min. Among those with a positive <i>meSDC2</i> test, a family history of CRC was a significant predictor of any CRN (p=0.029) and advanced neoplasia (p=0.003).</p><p><strong>Conclusions: </strong>A stool DNA-based meSDC2 test in average-risk individuals for CRC revealed a high PPV for any CRN in a real-world setting, highlighting its potential as a screening modality in programmatic CRC screening.</p>","PeriodicalId":94245,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"86 1","pages":"43-52"},"PeriodicalIF":0.8,"publicationDate":"2026-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12834636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146032255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Clinical Implementation of Artificial Intelligence in Endoscopy: A Human-Artificial Intelligence Interaction Perspective].","authors":"Eun Jeong Gong, Chang Seok Bang","doi":"10.4166/kjg.2025.151","DOIUrl":"10.4166/kjg.2025.151","url":null,"abstract":"<p><p>Artificial intelligence (AI) for gastrointestinal endoscopy has shown remarkable performance in detecting and characterizing lesions. A randomized controlled trial reported that AI significantly reduced the miss rates for gastric neoplasms, but real-world implementation studies have shown inconsistent results. This discrepancy cannot be explained solely by technical limitations. Regardless of the AI capabilities, the visualization quality and systematic inspection remain fundamental prerequisites, and traditional apprenticeship training cannot be replaced by technology. This review examines AI implementation in endoscopy from a human-AI interaction perspective. Two cognitive phenomena are relevant: 'automation neglect,' where experienced endoscopists dismiss AI recommendations due to overconfidence or distrust, and 'automation bias,' where users over-rely on AI outputs, potentially missing unhighlighted lesions. Recent evidence raises concerns regarding deskilling, with studies showing decreased diagnostic performance after exposure to AI. A systematic analysis of 52 human-AI teaming studies showed that none achieved ideal complementarity, and collaboration sometimes decreased accuracy compared to humans alone. AI effectiveness varies according to operator expertise. High-performing endoscopists gain minimal benefit, while those with intermediate experience show the greatest improvement. Nevertheless, excessive false-positive alerts can negate benefits. Strategies to address these challenges include explainable AI, human-centered design, structured education, trust calibration, and expertise-tailored AI systems. Maintaining human expertise remains paramount. AI is a powerful tool, but clinicians must remain the final decision maker. Periodic AI-free practice may be necessary to preserve clinical competence.</p>","PeriodicalId":94245,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"86 1","pages":"1-9"},"PeriodicalIF":0.8,"publicationDate":"2026-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12834635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146032236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Endoscopic Management of Chronic Pancreatitis].","authors":"Dong Woo Shin","doi":"10.4166/kjg.2025.121","DOIUrl":"10.4166/kjg.2025.121","url":null,"abstract":"<p><p>Chronic pancreatitis (CP) is a progressive fibroinflammatory disease characterized by pancreatic ductal obstruction, calcification, and fibrosis, leading to chronic pain and exocrine or endocrine insufficiency. Endoscopic management plays a central role in selected patients with painful obstructive CP, providing ductal decompression and drainage while avoiding the morbidity of surgery. Endoscopic retrograde cholangiopancreatography with pancreatic sphincterotomy, stenting, and stone extraction is the mainstay of therapy. Extracorporeal shock wave lithotripsy or pancreatoscopy-guided lithotripsy is recommended for radiopaque or large main pancreatic duct stones, whereas a single large-caliber plastic stent has been suggested for dominant ductal strictures. An endoscopic ultrasound guided celiac plexus block may be considered in patients with refractory pain unresponsive to medical or endoscopic therapy, even though its effect is usually transient. Endoscopic drainage is preferred over surgical or percutaneous approaches for uncomplicated pancreatic pseudocysts. A multidisciplinary approach involving endoscopists, surgeons, and pain specialists is essential, and early surgical consultation should be considered when endoscopic therapy fails or when complete ductal clearance is unlikely. This review summarizes current evidence and international guideline recommendations on the role of endoscopy in the management of chronic pancreatitis.</p>","PeriodicalId":94245,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"86 1","pages":"23-32"},"PeriodicalIF":0.8,"publicationDate":"2026-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12834634/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146032196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Current Status of Robotic Therapeutic Endoscopic Platforms].","authors":"Sang Hyun Kim","doi":"10.4166/kjg.2025.152","DOIUrl":"10.4166/kjg.2025.152","url":null,"abstract":"<p><p>Advances in gastrointestinal endoscopy have expanded its role from diagnosis to definitive therapy, leading to a paradigm shift in the management of gastrointestinal diseases. As therapeutic endoscopic procedures become increasingly complex, there is a growing demand for enhanced precision, stability, and control beyond the capabilities of conventional endoscopes. In response, various robotic endoscopic platforms have been developed to improve visualization, dexterity, and procedural safety, particularly for technically demanding interventions such as endoscopic submucosal dissection (ESD). Robotic therapeutic endoscopy systems can be broadly categorized into multitasking robotic platforms and robotic add-on platforms. Multitasking platforms enable bimanual manipulation, triangulation, and effective tissue traction but are often limited by high cost, system complexity, and workflow constraints. In contrast, robotic add-on platforms are designed to integrate with conventional endoscopes, offering improved maneuverability and traction with minimal disruption to clinical practice. Recent preclinical and early clinical studies, including first-in-human and randomized pilot trials, have demonstrated the feasibility and safety of robotic-assisted ESD, with potential benefits in procedural efficiency, learning curve reduction, and operator workload. Despite ongoing challenges related to cost-effectiveness, device integration, and widespread commercialization, robotic endoscopy represents a promising therapeutic platform. Continued technological refinement and accumulation of clinical evidence are expected to further define its role in advancing precision, standardization, and accessibility in therapeutic gastrointestinal endoscopy.</p>","PeriodicalId":94245,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"86 1","pages":"10-15"},"PeriodicalIF":0.8,"publicationDate":"2026-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12834640/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146032252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Functional Dyspepsia].","authors":"Sung Eun Kim, Yong Sung Kim, Ju Yup Lee, Boram Cha, Woori Na, Hye-Su You, Jeong Eun Shin","doi":"10.4166/kjg.2025.113","DOIUrl":"10.4166/kjg.2025.113","url":null,"abstract":"<p><p>Functional dyspepsia (FD) is defined as a clinical condition in which pain or discomfort arises from the gastroduodenal area in the absence of any organic, systemic, or metabolic disease that could explain the symptoms. Dyspeptic symptoms must be present for the previous three months with symptom onset at least six months before the diagnosis, according to the Rome IV criteria. Several factors have been suggested to induce the symptoms of FD, including disturbed gastroduodenal motility, visceral hypersensitivity, brain-gut interactions, duodenal low-grade mucosal inflammation, immune alteration, genetic susceptibility, and gut microbiota dysbiosis. Moreover, many patients with FD complain that specific foods trigger their symptoms, but the relationship between dietary or lifestyle factors and FD must be fully elucidated. Against this background, the Diet, Obesity, and Metabolism Research Study Group of the Korean Society of Neurogastroenterology and Motility developed visual materials outlining dietary and lifestyle factors relevant to functional gastrointestinal disorders to provide practical guidance for both clinicians and patients. This review introduces the FD section of these materials and provides a comprehensive summary of their contents.</p>","PeriodicalId":94245,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"85 4","pages":"451-458"},"PeriodicalIF":0.8,"publicationDate":"2025-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12580068/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145357396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Changing Epidemiology and Etiology of Upper Gastrointestinal Bleeding.","authors":"Hannah Lee, Jun-Won Chung, Kyoung Oh Kim, Kwang An Kwon, Jung Ho Kim","doi":"10.4166/kjg.2025.080","DOIUrl":"10.4166/kjg.2025.080","url":null,"abstract":"<p><p>Upper gastrointestinal bleeding (UGIB) is defined as bleeding from the esophagus, stomach, and duodenum, whereas lower gastrointestinal bleeding originates from below the ligament of Treitz, including the small bowel and colon. The incidence of UGIB has decreased globally over the past 20 years, reaching approximately 50-150 and 47 cases per 100,000 of the global population per year for variceal and non-variceal bleeding, respectively. The eradication of <i>Helicobacter pylori</i> and the widespread introduction of proton pump inhibitors have contributed to the current improvement in epidemiological outcomes. Regarding the etiology of UGIB, peptic ulcer disease is the most common cause, accounting for 43.6% of cases, followed by gastritis and duodenitis (27.6%), esophageal variceal bleeding (8.0%), and esophagitis (5.6%). Other causes, including malignancy, Dieulafoy's lesions, and Mallory Weiss tears, collectively account for 10-12% of UGIB. In conclusion, the outcomes of <i>H. pylori</i> eradication and the widespread introduction of proton pump inhibitors have offset the effects of an aging population. In addition, the increasing indications for non-steroidal anti-inflammatory drugs, anticoagulation, and antiplatelet agents have resulted in a decrease in the incidence of UGIB.</p>","PeriodicalId":94245,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"85 4","pages":"484-490"},"PeriodicalIF":0.8,"publicationDate":"2025-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12580070/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145357449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Follow-up and Management of Recurrent Nonmalignant Ampullary Neoplasms].","authors":"Dae Jung Kim, Min Jae Yang","doi":"10.4166/kjg.2025.055","DOIUrl":"10.4166/kjg.2025.055","url":null,"abstract":"<p><p>The widespread use of screening endoscopy has increased the detection rate of ampullary neoplasms. Most of these lesions are adenomas or carcinomas. The recurrence rates after an endoscopic papillectomy have been reported to range from 5% to 40%, even in cases with pathologically confirmed complete resection. An endoscopic mucosal resection (EMR) is commonly performed for residual or recurrent lesions, and endoscopic ablation therapies, such as argon plasma coagulation, may be used either as an alternative to or in conjunction with EMR. Recently, radiofrequency ablation (RFA) has garnered attention as a potential alternative to surgical treatment for intraductal residual or recurrent ampullary neoplasms after an endoscopic papillectomy, showing a 75.7% clinical success rate. In cases of recurrence after initial RFA, additional RFA has enabled oncologic control in nearly all patients without the need for surgery. Nevertheless, further prospective studies and accumulation of evidence are necessary to establish the efficacy and safety of RFA in this setting.</p>","PeriodicalId":94245,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"85 4","pages":"431-434"},"PeriodicalIF":0.8,"publicationDate":"2025-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12580053/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145357363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Irritable Bowel Syndrome].","authors":"Boram Cha, Jeong Eun Shin, Woori Na, Sung Eun Kim, Ju Yup Lee, Hyesu You, Yong Sung Kim","doi":"10.4166/kjg.2025.112","DOIUrl":"10.4166/kjg.2025.112","url":null,"abstract":"<p><p>Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent abdominal pain in the absence of detectable organic, systemic, or metabolic disease. According to the Rome IV criteria, symptoms must have begun at least six months before and be present during the preceding three months for diagnosis. The proposed mechanisms underlying IBS include abnormal intestinal motility, visceral hypersensitivity, altered brain-gut interactions, low-grade mucosal inflammation, immune dysregulation, genetic predisposition, and gut microbiota imbalance. Although many patients report food-related symptom triggers, the relationship between dietary or lifestyle factors and IBS is unclear. The Diet, Obesity, and Metabolism of the Korean Society of Neurogastroenterology and Motility addressed this gap by developing visual educational materials on dietary and lifestyle strategies for functional gastrointestinal disorders. This review summarizes the section devoted to IBS and provides a comprehensive overview of its practical recommendations for clinicians and patients.</p>","PeriodicalId":94245,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"85 4","pages":"459-466"},"PeriodicalIF":0.8,"publicationDate":"2025-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12580054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145357411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Percutaneous Transhepatic Biliary Intervention for The Management of Malignant Hilar Biliary Obstruction.","authors":"Quoc Huy Vo, Minh Tuan Le, Dac Hong An Ngo, Ba Khanh Minh Le, Huu Thien Ho, Trong Khoan Le, Thanh Thao Nguyen, Quang Hung Dang, Hoang Huy Le, Trong Binh Le","doi":"10.4166/kjg.2025.073","DOIUrl":"10.4166/kjg.2025.073","url":null,"abstract":"<p><strong>Background/aims: </strong>This study evaluated the short-term safety and effectiveness of percutaneous transhepatic biliary drainage (PTBD) for a malignant hilar biliary obstruction (MHBO).</p><p><strong>Methods: </strong>The data from 112 patients with MHBO who underwent PTBD between January 2019 and June 2024 were analyzed retrospectively. All MHBO was confirmed pathologically. Technical success was defined as the placement of a drainage tube within the biliary tract. Clinical success was defined as a decrease in the total bilirubin level of ≥20% within seven days post-procedure. The 30-day morbidity, mortality, and re-intervention were documented. One interventional radiologist with 15 years of experience performed all procedures.</p><p><strong>Results: </strong>The average age was 62.6±12.3 years (range, 28-91 years), and the female-to-male ratio was 2:3. The most common etiology of MHBO was cholangiocarcinoma (68.8%). The Bismuth-Corlette classification scores were as follows: type 1 (17.9%), type 2 (23.2%), type 3A (25.9%), type 3B (16.0%), and type 4 (17.0%). The technical success rate was 99.1%; 41.4% of PTBD were bilateral, and 82% were internal-external drainage. Preoperative drainage and palliative drainage were indicated in 28.6% and 71.4% of cases, respectively. Biliary stents were implanted in 39 patients (35.1%), including 51.3% unilateral stents, 23.1% Y-stents, 20.5% kissing stents, and 5.1% T-stents. The clinical success rate was 69.6%. The minor complication rate was 18.8%. The 30-day re-intervention and mortality rates were 24.1% and 1.8%, respectively.</p><p><strong>Conclusions: </strong>PTBD was safe and effective in managing MHBO. Further study of this specific subgroup and long-term follow-up is warranted.</p>","PeriodicalId":94245,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"85 4","pages":"517-526"},"PeriodicalIF":0.8,"publicationDate":"2025-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12580063/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145356944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Rectal Tailgut Cyst treated with Endoscopic Mucosal Resection: A Case Report and Literature Review.","authors":"Je-Seong Kim, Young-Eun Seo, Chae-June Lim, Hyung-Hoon Oh, Chan-Muk Im, Ki-Hyun Kim, Sung-Bum Cho, Myung-Giun Noh, Young-Eun Joo","doi":"10.4166/kjg.2025.085","DOIUrl":"10.4166/kjg.2025.085","url":null,"abstract":"<p><p>A tailgut cyst is a rare tumor arising from the persistent embryonic remnants of the postanal gut. The cyst is usually located in the retrorectal space, lying anterior to the sacrum and posterior to the rectum. In rarer cases, it is occasionally found at the perirenal, perianal, subcutaneous, and intradural sites. A 60-year-old woman visited the authors' clinic for a routine health screening examination. Colonoscopy revealed a subepithelial tumor, measuring 5 mm in diameter and located in the lower rectum near the anal sphincter, which may be a neuroendocrine tumor. An endoscopic mucosal resection (EMR) was performed for an accurate histologic diagnosis and treatment, and the rectal lesion was completely removed <i>en bloc</i> and then diagnosed as a tailgut cyst. This paper reports a case of a rectal tailgut cyst treated with EMR in a 60-year-old woman. The 12-month follow-up showed no evidence of recurrence. To the best of the authors' knowledge, this is the second reported case worldwide of a rectal tailgut cyst successfully treated with an EMR, and the first such case reported in Korea.</p>","PeriodicalId":94245,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"85 4","pages":"549-553"},"PeriodicalIF":0.8,"publicationDate":"2025-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12580061/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145357412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}